Sponsored By

Stroke-Detection Startup Gets Boost from European Investors

Qmed Staff

August 30, 2013

1 Min Read
Stroke-Detection Startup Gets Boost from European Investors

Jan Medical (Mountain View, CA) landed Series B funding from Brainlab, a German-based investor. Armed with the additional funds, the company will continue its pursuit of FDA approval for its ischemic stroke system. The device can also be used to detect concussions. While the company didn't disclose the total investment amount, it's believed to be above $3.15 million.

According to the company, new funding for the Nautilus NeuroWave is valuable in today's market. Since venture funding for diagnostics and medical devices has been depressed, the latest cash infusion is good news for the company. The stroke / concussion-detection device, dubbed Nautilus NeuroWave, can detect abnormalities in a patient's brain faster than existing technologies. In particular, the device can detect cerebral abnormalities with a higher level of precision than traditional imaging systems.

The novel device currently has an Investigational Device Exemption (IDE) in the United States. In many cases, the Nautilus NeuroWave can diagnose the health of a patient's brain in only a few seconds.

While ischemic strokes are treatable with current medical technologies, there is only a small window where treatment is effective. However, most modern brain imaging techniques are ineffective at detecting an ischemic stroke. While there are advanced imaging options, these are not widely available and can take more time than a traditional CT scan.

"Patient outcomes will be enhanced, as healthcare providers will have clinically relevant and timely information to treat their patients faster, at lower cost and with less risk," notes Paul Lovi, president and CEO of Jan Medical.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like